These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 31242683)

  • 1. Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis.
    Abdul Razzak R; Florence GJ; Gunn-Moore FJ
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
    Tashima T
    Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
    Choi ES; Shusta EV
    Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.
    Wang Q; Zuo Z
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):961-972. PubMed ID: 30118608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mfsd2a is critical for the formation and function of the blood-brain barrier.
    Ben-Zvi A; Lacoste B; Kur E; Andreone BJ; Mayshar Y; Yan H; Gu C
    Nature; 2014 May; 509(7501):507-11. PubMed ID: 24828040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.
    Zhang W
    Handb Exp Pharmacol; 2024; 284():213-230. PubMed ID: 37528323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
    Abbott NJ
    J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics.
    Ronaldson PT; Davis TP
    Expert Opin Drug Deliv; 2024; 21(1):71-89. PubMed ID: 38217410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting transporters for CNS drug delivery.
    Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1419-21. PubMed ID: 23789947
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).
    Helms HCC; Kristensen M; Saaby L; Fricker G; Brodin B
    Handb Exp Pharmacol; 2022; 273():151-183. PubMed ID: 33367937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
    Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
    Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
    Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
    CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.
    Strazielle N; Ghersi-Egea JF
    Curr Pharm Des; 2016; 22(35):5463-5476. PubMed ID: 27464721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcellular brain drug delivery: A review on recent advancements.
    Azarmi M; Maleki H; Nikkam N; Malekinejad H
    Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.
    Banks WA
    Nat Rev Drug Discov; 2016 Apr; 15(4):275-92. PubMed ID: 26794270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting blood-brain-barrier transcytosis - perspectives for drug delivery.
    Mäger I; Meyer AH; Li J; Lenter M; Hildebrandt T; Leparc G; Wood MJA
    Neuropharmacology; 2017 Jul; 120():4-7. PubMed ID: 27561970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal drug delivery to the central nervous system: present status and future outlook.
    Tayebati SK; Nwankwo IE; Amenta F
    Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.